Valiant Laboratories Ltd

Valiant Laboratories Ltd, a player in the Pharmaceuticals & Biotechnology sector, has recorded a new all-time low of Rs.63.05, marking a significant milestone in its ongoing decline. The stock’s performance continues to lag behind key market indices and sector benchmarks, reflecting persistent pressures on its valuation and financial metrics.

Valiant Laboratories Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 17 Nov 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 14 January 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.

Valiant Laboratories Ltd, a player in the Pharmaceuticals & Biotechnology sector, recorded a new 52-week low of Rs.63.45 today, marking a significant decline in its stock price amid broader market movements and company-specific performance factors.

Valiant Laboratories Ltd, a player in the Pharmaceuticals & Biotechnology sector, has reached a new all-time low of Rs.63.45, marking a significant milestone in its ongoing decline. The stock’s recent performance reflects a sustained period of underperformance relative to both its sector and broader market indices.

Valiant Laboratories Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 17 Nov 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 03 January 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance.

Valiant Laborato, a microcap player in the Pharmaceuticals & Biotechnology sector, has experienced a revision in its market evaluation reflecting ongoing challenges in its financial and technical outlook. The recent adjustment highlights shifts in key analytical parameters that investors should consider amid the company’s subdued performance and valuation concerns.

Valiant Laboratories, a player in the Pharmaceuticals & Biotechnology sector, has reached a new 52-week low of Rs 63.5, marking a significant price level for the stock amid broader market fluctuations.

Valiant Laboratories, a player in the Pharmaceuticals & Biotechnology sector, has reached an all-time low in its stock price, reflecting a sustained period of underwhelming market performance and financial metrics that highlight ongoing difficulties within the company’s operations and valuation.

Valiant Laboratories, a player in the Pharmaceuticals & Biotechnology sector, has reached a new 52-week low of Rs.64.23, marking a significant price level for the stock amid a broader market environment that has seen mixed movements.

Valiant Laboratories has reached a new 52-week low, with its stock price touching Rs.64.23 today. This marks a significant decline for the pharmaceutical and biotechnology company, reflecting ongoing challenges in its market performance and valuation metrics.

Valiant Laboratories, a player in the Pharmaceuticals & Biotechnology sector, has reached an all-time low in its stock price, reflecting a sustained period of subdued market performance and financial metrics that highlight ongoing difficulties within the company.

Valiant Laborato, a microcap player in the Pharmaceuticals & Biotechnology sector, has experienced a revision in its market evaluation reflecting ongoing challenges in its financial and technical outlook. The stock’s recent performance and fundamental indicators highlight a complex scenario for investors navigating this segment.

Valiant Laboratories, a player in the Pharmaceuticals & Biotechnology sector, has reached a new 52-week low of Rs.66, marking a significant decline in its stock price amid subdued market conditions and sector underperformance.

Valiant Laboratories has reached a new 52-week low, with its share price touching Rs.66 today. This marks a significant decline for the pharmaceutical and biotechnology company, reflecting ongoing pressures in its market performance and valuation metrics.

Valiant Laboratories, a player in the Pharmaceuticals & Biotechnology sector, has reached an all-time low in its stock price, reflecting a sustained period of subdued market performance and financial metrics that highlight ongoing pressures within the company.

Valiant Laboratories, a player in the Pharmaceuticals & Biotechnology sector, has reached a new 52-week low of Rs.68.11, marking a significant price level for the stock amid a broader market environment showing resilience.

Valiant Laboratories, a player in the Pharmaceuticals & Biotechnology sector, has reached a new all-time low of Rs. 68.11, marking a significant point in its recent market performance. The stock’s decline contrasts sharply with broader market indices and sector trends, reflecting a challenging phase for the company.

Valiant Laboratories, a player in the Pharmaceuticals & Biotechnology sector, has reached a new 52-week low of Rs.68.46, marking a significant decline amid a broader market environment where the Sensex trades near its yearly highs.

Valiant Laboratories has reached a new 52-week low, closing at Rs.68.46 today, marking a significant decline amid a broader market environment where the Sensex remains near its yearly highs. The stock has experienced a notable downward trend over the past three days, reflecting ongoing pressures within the Pharmaceuticals & Biotechnology sector.